First Mercantile Trust’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$132K Sell
2,649
-44
-2% -$2.4K 0.02% 563
2021
Q2
$149K Sell
2,693
-317
-11% -$16.9K 0.02% 547
2021
Q1
$141K Sell
3,010
-353
-10% -$17.1K 0.02% 565
2020
Q4
$146K Sell
3,363
-10
-0.3% -$369 0.02% 556
2020
Q3
$121K Buy
+3,373
New +$115K 0.01% 613

Other funds holding HCAT

First Mercantile Trust's HCAT Position: Q3 2021 in Review

First Mercantile Trust reduced its Health Catalyst (HCAT) stake by 1.6% in Q3 2021, selling an estimated $2.4K and leaving 2,649 shares worth $132K. The position accounts for 0.02% of the portfolio, ranked #563.

First Mercantile Trust first reported a position in HCAT in Q3 2020 and has held it in 5 quarters since. The position peaked at $149K in Q2 2021. 198 funds tracked by Wall St. Rank hold HCAT as of Q3 2021.

  • First Mercantile Trust held 2,649 shares of Health Catalyst worth $132K as of Q3 2021.
  • First Mercantile Trust sold 44 Health Catalyst shares in Q3 2021, an estimated $2.4K.
  • Health Catalyst made up 0.02% of First Mercantile Trust's portfolio in Q3 2021, its #563 holding.
  • First Mercantile Trust first reported a position in Health Catalyst in Q3 2020 and has held it in 5 quarters since.
  • First Mercantile Trust's Health Catalyst position peaked at $149K in Q2 2021.
  • 198 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2021.

Based on First Mercantile Trust's 13F filing for Q3 2021, filed 24 Nov 2021.